Anja von Heydebreck

Variance stabilization applied to microarray data calibration and to the quantification of differential expression

Wolfgang Huber, Anja von Heydebreck, Holger Sültmann et al. · Bioinformatics · 2002 · 2.6K citations · Full text

Life Sciences, Bioinformatics, Biostatistics +13

Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial

Howard L. Kaufman, Jeffery S. Russell, Omid Hamid et al. · The Lancet Oncology · 2016 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +11

Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study

Luc Dirix, István Takács, Guy Jérusalem et al. · Breast Cancer Research and Treatment · 2017 · 756 citations · Full text

Medicine, Oncology, Pharmacology +17

EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study

Robert Pirker, Jose R. Pereira, Joachim von Pawel et al. · The Lancet Oncology · 2011 · 574 citations

Medicine, Oncology, Pharmacology +17

Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer

Mary L. Disis, Matthew H. Taylor, Karen Kelly et al. · JAMA Oncology · 2019 · 427 citations · Full text

Medicine, Oncology, Pharmacology +15